Astragalus saponins Inhibits Lipopolysaccharide-Induced Inflammation in Mouse Macrophages

Keyphrases

• Inflammatory Diseases 100%
• P38 Mitogen-activated Protein Kinase (p38 MAPK) 100%
• Nitric Oxide 100%
• Leukemia 100%
• 5-fluorouracil (5-FU) 100%
• Lipopolysaccharide 100%
• Lipopolysaccharide-induced 100%
• Astragalus Saponins 100%
• Lipopolysaccharide-induced Inflammation 100%
• Mouse Macrophages 100%
• Anti-inflammation 50%
• Inflammation 50%
• Peripheral Blood Mononuclear Cells 50%
• Inflammatory Cytokines 50%
• Tumor Necrosis Factor-α 50%
• Cytotoxicity 50%
• Phosphorylation 50%
• Normal Human 50%
• Nitric Oxide Inhibition 50%
• Inducible Nitric Oxide Synthase 50%
• Non-cytotoxic 50%
• T Cells 50%
• Cytotoxic Concentration 50%
• Nuclear factor-B 50%
• Growth Inhibition 50%
• Cytotoxic Effect 50%
• Inflammatory Response 50%
• Anticancer Drugs 50%
• Mitogen-activated Protein Kinase 50%
• Saponins 50%
• Induced Growth 50%
• Nitric Oxide Release 50%
• Beneficial Effects 50%
• Insults 50%
• Astragalus Membranaceus 50%
• HL-60 Cells 50%
• RAW264.7 Macrophages 50%
• Tumor Development 50%
• Immune System 50%
• White Blood Cell Count 50%
• Hematotoxicity 50%
• Jurkat Cells 50%
• Hematocrit 50%
• Immunomodulating 50%
• Inflammation-associated Cancer 50%
• Cytokine Release 50%
• Promyelocytic 50%
• Hematologic 50%
• Protein Overexpression 50%
• Gene Overexpression 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Saponin 100%
• Lipopolysaccharide 100%
• Astragalus 100%
• Lipopolysaccharide-Induced Inflammation 100%
• Nitric Oxide 75%
• Cytokine 50%
• Cytotoxicity 50%
• Inflammation 50%
• Inflammatory Disease 50%
• Mitogen Activated Protein Kinase P38 50%
• Tumor Necrosis Factor 25%
• Side Effect 25%
• Malignant Neoplasm 25%
• Antiinfective Agent 25%
• Normal Human 25%
• Neoplasm 25%
• Anti-Inflammation 25%
• Nuclear Factor 25%
• Anticancer Drug 25%
• Alternative Complement Pathway C3 C5 Convertase 25%
• Inducible Nitric Oxide Synthase 25%
• Astragalus membranaceus 25%